American College of Clinical Pharmacy
      Search      Cart

BCACP and BCGP Clinical Session -- When Life Happens: Managing Diabetes in the Older Adult Across the Continuum of Care

Monday, October 28, 2019 from 11:00 AM to 12:30 PM EST at 2nd Floor: Beekman/Sutton North

Available for 1.50 hours of CPE credit
Activity Number: 0204-9999-19-246-L01-P
Activity Type: An Application-Based Activity

The BCACP and BCGP Clinical Sessions are part of the professional development program for the recertification of board-certified ambulatory care pharmacists and board-certified geriatric pharmacists, approved by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCACP and BCGP recertification credit, participants must attend the session, claim the continuing pharmacy education credit, and then must pass the associated posttest. Access to the BCACP and BCGP Clinical Sessions posttests will be available on December 17, 2019 at to anyone who has purchased access to the BCACP or BCGP posttests. For participants who have not purchased access to the posttest, access can be purchased until 5:30 p.m. on Tuesday, October 29, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be June 17, 2020.

  • Amie Taggart Blaszczyk, Pharm.D., CGP, BCPSSpeaker: Amie Taggart Blaszczyk, Pharm.D., CGP, BCPS
    Associate Professor and Division Head – Geriatrics, Texas Tech University School of Pharmacy, Dallas, Texas
      View Biography

  • Dana G. Carroll, Pharm.D., BCGP, BCPS, CDESpeaker: Dana G. Carroll, Pharm.D., BCGP, BCPS, CDE
    Clinical Professor, Auburn University Harrison School of Pharmacy, Auburn, Alabama
      View Biography

Learning Objectives
1. Design a treatment regimen for an older adult with diabetes mellitus taking into consideration therapeutic goals and other patient-related variables.
2. Develop a care plan for an older adult patient with diabetes mellitus who is making the transition from one geriatric care setting to another.
3. Summarize the safety and administration concerns with diabetes medications that should be communicated to patients, caregivers and related healthcare providers across the spectrum of geriatric care settings.
4. Evaluate the evidence base for the use of diabetic medications in the older adult.
5. Generate practical advice for their use of these agents in this patient population.